Please login to the form below

Not currently logged in
Email:
Password:

Ron Tilles

This page shows the latest Ron Tilles news and features for those working in and with pharma, biotech and healthcare.

Shkreli fallout claims Turing jobs and KaloBios' listing

Shkreli fallout claims Turing jobs and KaloBios' listing

It will also expand its board. Chairman and interim CEO Ron Tilles said reducing the headcount would "put us in the best position to continue executing on our long-term plan".

Latest news

  • Update: Shkreli resigns as Turing CEO, ousted from KaloBios Update: Shkreli resigns as Turing CEO, ousted from KaloBios

    Shkreli will be replaced on an interim basis by Ron Tilles, Turing Pharma's chairman, at the privately held company, which has offices in New York and Zug in Switzerland. ... In a statement, Tilles thanked Shkreli for his time at Turing and wished him

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Lars Bruening
Shaping healthcare
Bayer’s Lars Bruening talks about moving to the UK as the market works its way through a series of seismic changes...
No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...

Infographics